You are here

Germany

AbbVie Invests €150 million in New German Development Facility

European Pharmaceutical Manufacturer

Mon, 05/6/24 - 05:58 pm

drug development

Germany's Merck breaks ground on $321m biomanufacturing center

BioProcess International

Thu, 04/25/24 - 05:57 pm

drug manufacturing

Daiichi invests 1 bln eur near Munich to make precision cancer drugs

Reuters

Fri, 02/16/24 - 11:51 am

precision medicine

Santhera debuts DMD drug Agamree in Germany

Pharmaphorum

Mon, 01/15/24 - 09:37 am

Duchenne Muscular Dystrophy

BioMarin secures hemophilia gene therapy coverage in Germany

BioPharma Dive

Wed, 11/29/23 - 11:35 pm

German regulator eyes Ozempic export ban amid shortages across Europe

Reuters

Wed, 11/15/23 - 11:19 am

Will US Pharma See Lawsuits over COVID Vaccine Side Effects?

BioSpace

Tue, 06/20/23 - 10:13 am

Boehringer Ingelheim breaks ground on €285M API plant in Germany

Fierce Pharma

Wed, 05/3/23 - 11:35 am

Boehringer Ingelheim

drug manufacturing

Boehringer Ingelheim opens new biotechnology R&D center in Germany

Pharmaceutical Business Review

Tue, 04/25/23 - 10:42 am

Boehringer Ingelheim

Bristol Myers axes German launch of new cancer drug, citing pricing hurdles

Endpoints

Tue, 03/7/23 - 10:37 pm

Bristol Myers Squibb

BioNTech completes first in-house plasmid DNA manufacturing facility

Biopharma Reporter

Thu, 02/2/23 - 10:39 am

drug manufacturing

CSL takes the wraps off a big new R&D center as it eyes vaccines, cell and gene therapies

Endpoints

Wed, 09/14/22 - 09:32 am

Merck KGaA continues expansion with $285M+ investment in 2 new projects in France and Germany

Endpoints

Fri, 09/9/22 - 11:13 am

drug manufacturing

GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contracts

Fierce Pharma

Mon, 04/11/22 - 10:33 am

BioNTech wins 5-year mRNA vaccine deal with German government

Yahoo/Reuters

Fri, 04/8/22 - 10:18 am

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Fierce Pharma

Thu, 03/17/22 - 10:20 am

As Omicron-specific boosters are in the news, BioNTech to expand German site workforce by 200 employees

Endpoints

Thu, 01/27/22 - 10:44 am

Omicron COVID-19 variant

Evotec receives €7.5m grant to develop COVID-19 therapeutic

Biopharma Reporter

Mon, 01/3/22 - 10:40 am

Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag

Fierce Pharma

Tue, 04/20/21 - 07:38 pm

Thermo Fisher aims to boost its clinical offerings with German expansion — including cold chain for the Covid-19 effort

Endpoints

Wed, 12/16/20 - 10:53 am

Pages